Daiana Ibarretxe - Concepedia

Author

Daiana Ibarretxe

Institut d'Investigació Sanitària Pere Virgili ORCID

Also Known As

D Ibarretxe, D. Ibarretxe, Daiana Ibarretxe, Diana Ibarretxe

136

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Institut d'Investigació Sanitària Pere Virgili Universitat Rovira i Virgili Hospital Universitari Sant Joan de Reus Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas Centro de Investigación Biomédica en Red

About

Daiana Ibarretxe is an author at Institut d'Investigació Sanitària Pere Virgili specializing in atherosclerosis, medicine, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	308
2	Public Health	7	7	164
3	Health Sciences	6	6	110
4	Biochemistry	3	3	41
5	Natural Sciences	1	1	13

Daiana Ibarretxe

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Low HDL and high triglycerides predict COVID-19 severity L. Masana, Eudald Correig, Daiana Ibarretxe, Scientific Reports	2021	192
HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk Josefa Girona, Núria Amigó, Daiana Ibarretxe, International Journal of Molecular Sciences	2019	99
The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario Josefa Girona, Cèlia Rodríguez-Borjabad, Daiana Ibarretxe, Journal of Clinical Medicine	2019	62
Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia Tawfeg Ben‐Omran, L. Masana, Genovefa Kolovou, Advances in Therapy	2019	53
Long-term exposure to PM10 above WHO guidelines exacerbates COVID-19 severity and mortality Montse Marquès, Eudald Correig, Daiana Ibarretxe, Environment International	2021	46
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society María José Ariza, José Rioja, Daiana Ibarretxe, Journal of clinical lipidology Metabolic SyndromeFamilial Chylomicronemia SyndromeEpidemiologyLipid DisorderCardiovascular Disease	2018	43
Lipid lowering combination therapy: From prevention to atherosclerosis plaque treatment L. Masana, Núria Plana, Natàlia Andreychuk, Pharmacological Research	2023	40
Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases Josefa Girona, Daiana Ibarretxe, Núria Plana, Cardiovascular Diabetology	2016	37
Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk Montse Guardiola, Núria Plana, Daiana Ibarretxe, Clinical Science Vascular DiseaseCardiometabolic RiskHigh Cardiovascular RiskHyperlipidemiaObesity	2015	31
Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis María José Ariza, Pedro Luis Martínez-Hernández, Daiana Ibarretxe, Journal of clinical lipidology Pancreatic CancerGeneticsNovel MutationsGastroenterologyPathology	2015	30

Page 1